A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants
Clinical trial NCT06049095 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06049095
- Sponsor
- Latigo Biotherapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-17
- Primary completion
- 2026-09-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.